Codex now controls Windows PCs directly OpenAI launches Rosalind Biodefense initiative Anthropic raises $65B in Series H funding Anthropic raises $65B in Series H Claude Opus 4.8 Now Available on Web, Platform and Cloud Claude Opus 4.8 now available on web and API Anthropic adds Fast mode to Claude Opus 4.8 Anthropic launches Claude Opus 4.8 with better task control Anthropic raises $65B in Series H funding Anthropic releases Claude Opus 4.8 with faster workflows OpenAI makes GPT-5.5 Instant easier to read Dynamic Workflows Added to Claude Code in Research Preview Gemini Omni enables conversational content editing OpenAI publishes 2026 election safeguards SynthID Watermarking Expanded with OpenAI Partnership Anthropic updates Responsible Scaling Policy v3.2 OpenAI updates ChatGPT ad policy criteria Anthropic explains how it contains Claude Google DeepMind expands AI safety partnership with Singapore Anthropic finds over 10,000 vulnerabilities with Project Glasswing Codex now controls Windows PCs directly OpenAI launches Rosalind Biodefense initiative Anthropic raises $65B in Series H funding Anthropic raises $65B in Series H Claude Opus 4.8 Now Available on Web, Platform and Cloud Claude Opus 4.8 now available on web and API Anthropic adds Fast mode to Claude Opus 4.8 Anthropic launches Claude Opus 4.8 with better task control Anthropic raises $65B in Series H funding Anthropic releases Claude Opus 4.8 with faster workflows OpenAI makes GPT-5.5 Instant easier to read Dynamic Workflows Added to Claude Code in Research Preview Gemini Omni enables conversational content editing OpenAI publishes 2026 election safeguards SynthID Watermarking Expanded with OpenAI Partnership Anthropic updates Responsible Scaling Policy v3.2 OpenAI updates ChatGPT ad policy criteria Anthropic explains how it contains Claude Google DeepMind expands AI safety partnership with Singapore Anthropic finds over 10,000 vulnerabilities with Project Glasswing

Official sources only. Rumors, leaks, and get-rich schemes are excluded.

← Back to top

OpenAI19:33Feature UpdatesOfficial Blog

OpenAI Releases GPT-Rosalind for Life Sciences

Accelerates hypothesis testing with scientific tools, expanding drug discovery options.

Key Points

1Superior in protein/chem reasoning & genomics.
2Available now in ChatGPT, Codex, API.
3Preview for Amgen, Moderna, etc.
4Aids shortening 10-15yr drug approval.

OpenAI introduced GPT-Rosalind, a frontier reasoning model for biology, drug discovery, and translational medicine in research preview. It excels in protein/chemical reasoning, genomics, and tool use, available via ChatGPT, Codex, and API for customers like Amgen and Moderna. Researchers can test hypotheses faster, shortening drug development timelines.

What changed

OpenAI introduced GPT-Rosalind, a frontier reasoning model for biology, drug discovery, and translational medicine in research preview. It excels in protein/chemical reasoning, genomics, and tool use, available via ChatGPT, Codex, and API for customers like Amgen and Moderna. Researchers can test hypotheses faster, shortening drug development timelines.

Why it matters

Accelerates hypothesis testing with scientific tools, expanding drug discovery options.

What to watch

Accelerates hypothesis testing with scientific tools, expanding drug discovery options. Key checks: Superior in protein/chem reasoning & genomics. / Available now in ChatGPT, Codex, API. / Preview for Amgen, Moderna, etc..

📎 Source: Official Blog